Frontlight ResearchEarly access
Psoriatic arthritis trials in Poland
1 of 12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Poznan, Wroclaw
- Age
- 18 years to 75 years
- People
- 1,200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693